Use of a glucocorticoid composition for the treatment of severe and uncontrolled asthma

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8668901
SERIAL NO

13147761

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Methods, devices and compositions for treatment of severe and uncontrolled asthma are provided by which high amounts of an inhaled corticosteroid are directed to the small airways of the lower lungs. The invention provides for a substantial decrease in the dose of concurrently administered oral corticosteroids. A particular advantage of the invention is the significant reduction in corticosteroid-related adverse effects.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
VECTURA GMBH82131 GAUTING

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Hofmann, Thomas Doylestown, US 157 2776
Kroneberg, Philipp Olching, DE 6 132
Muellinger, Bernard Munich, DE 2 23
Scheuch, Gerhard Wohrathal, DE 19 360

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Sep 11, 2025
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00